Mediview Announces New Advisory Board Member
Sep 19, 2022
MediView is pleased to announce the addition of Dr. Anand Patel as a new member to MediView’s Advisory Board.
“Dr. Patel has been part of the development, commercialization, and reimbursement of an impressive list of medical devices,” said MediView President & CEO, Mina Fahim. “His clinical expertise, healthcare economics proficiency, and involvement with the startup technology and investment ecosystem are helping MediView grow in this next phase of simplifying medical procedures with “X-ray vision”.”
Dr. Patel has a BSE in Bioengineering from the University of Pennsylvania, and an MD from Harvard Medical School. He completed his Radiology Residency and Interventional Radiology Fellowship at UC San Francisco. Dr. Patel’s experience in clinical practice, R&D, lower/middle market companies, and healthcare operations has allowed him to provide value to multiple startups and investment firms over the last decade. He has helped companies grow from early stage to IPO with valuations over $10B. Dr. Patel’s interests are in interventional/diagnostic radiology, advanced visualization, consumer/digital health, med devices, and artificial intelligence. Dr. Patel has also worked extensively with over a dozen med tech companies and has operational experience with capital raising, advanced R&D, product development, management, marketing, clinical implementation, FDA clearance, and CMS reimbursement. He was previously Founder/CEO of an NIH funded startup in the interventional radiology space based on a chemotherapy medical device. Dr. Patel’s work has been published in multiple peer-reviewed publications and he has presented at numerous international conferences. He continues to work with multiple University of California campuses on several technology development initiatives.
by Charlie Fink | forbes.com